Long-term abuse of drug use and stimulant drugs such as methamphetamine has many negative consequences, including mental disorders, for instance, schizophrenia. The basis for the behaviors exhibited by schizophrenics, described in particular in the current case: paranoia, severe excitation coupled with periods of gloom and darkness, and a desire to commit suicide, are signs of drug use. Treatment should be produced into an involuntary mental institution with the help of dopamine agonists and antagonists.
Schizophrenia and other mental health problems reflect the substantial changes in the brain caused by methamphetamine use. Studies have demonstrated the presence of changes in the dopamine system, which are associated, on the one hand, with arousal and hallucinations and, on the other, with psychological decay and depression (“National Institute on Drug Abuse,” 2020). Dysfunction of multiple systems in schizophrenia indicates that medication targeting one side of neurotransmission will not be effective (Li et al., 2016). Hence, treatment should involve the modulation of dopamine agonists and antagonists.
To summarize, treatment of schizophrenia should be done through a stepwise synthesis of dopamine agonists and antagonists into an involuntary mental institution. In particular, the former aims to reduce symptoms such as experiencing gloom, darkness, and a desire to commit suicide. At the same time, the latter seeks to eliminate hallucinations, for instance, hearing that other people are planning a kidnapping, which was observed from a current patient, as well as severe excitation.
References
Li, P., Snyder, G. L., & Vanover, K. E. (2016). Dopamine targeting drugs for the treatment of schizophrenia: Past, present and future. Current Topics in Medicinal Chemistry, 16(29), 3385–3403.
National Institute on Drug Abuse. (2020). What are the long-term effects of methamphetamine misuse?